Because the total number of cells was also increased two-fold in the lymph nodes of tumor-treated animals, the total increase in CD4+ CD25+ Foxp3+ was approximately four-fold, compared to the PBS-injected animals (Fig. 3A). The gene discussed is CD4; the disease is neoplasm.